We showed that STAT3 is constitutively active in CLL cells, being phosphorylated on Ser727 and Tyr705, and that the block of JAK2/STAT3 pathway by specific inhibitors affects the viability of the neoplastic clone, overcoming the bone marrow environmental protection. Here, STAT3 is linked to B-cell chronic lymphocytic leukemia.